Markets

It’s worth it to have a look at Amgen Inc. (AMGN)

Amgen Inc. (NASDAQ:AMGN) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now trading with a market value of 122.88B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

Amgen Inc. (NASDAQ:AMGN) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For AMGN, the company currently has 9.74 billion of cash on the books, which is offset by 2.18 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 71.16 billion in total assets, balanced by 55.54 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Amgen Inc. (AMGN) saw 2.57 billion in free cash flow last quarter, representing a quarterly net change in cash of 5.94 billion. Perhaps most importantly where cash movements are concerned, the company saw about 2.73 billion in net operating cash flow.

Amgen Inc. (NASDAQ:AMGN) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 5.59 billion in total revenues. That represents a quarterly year/year change in revenues of 0.03 in sequential terms, the AMGN saw sales decline by -0.04.



But what about the bottom line? After all, that’s what really matters in the end. Amgen Inc. (AMGN) is intriguing when broken down to its core data. The cost of selling goods last quarter was 944 million, yielding a gross basic income of 4.64 billion. For shareholders, given the total diluted outstanding shares of 711 million, this means overall earnings per share of 3.25. Note, this compares with a consensus analyst forecast of 3.49 in earnings per share for its next fiscal quarterly report.

Is Amgen Inc. (NASDAQ:AMGN) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 14.09 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 12.33. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Amgen Inc..

Previous ArticleNext Article

Related Post

Altria Group, Inc. (MO): More In-Depth Monitoring ... Altria Group, Inc. (NYSE:MO) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now tra...
A Side-by-side Analysis of Target Corporation (TGT... Target Corporation (NYSE:TGT) shares are down more than -22.12% this year and recently decreased -1.52% or -$0.87 to settle at $56.25. Dollar Tree, In...
Looking at the Big Picture for Pinnacle Foods Inc.... Pinnacle Foods Inc. (NYSE:PF) trade is getting exciting but lets take a deeper look whether it is as good a moment. Now trading with a market value of...
PulteGroup, Inc. (PHM) Makes An Interesting Case R... It's worth it to have a look at PulteGroup, Inc. (NYSE:PHM) as there may be a chasm between the bulls and the bears as far as recent trading activity ...
What Recent Ownership Trends Suggest About Regions... Recent insider trends for Regions Financial Corporation (NYSE:RF) have caught the attention of investors. Patters in insider activity can help analyst...